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There are increased risks of contracting COVID-19 in hospitals and long-term care facilities, particularly
for vulnerable groups. In these environments aerosolised coronavirus released through breathing
increases the chance of spreading the disease. To reduce aerosol transmissions, the use of low dose
far-UVC lighting to disinfect in-room air has been proposed. Unlike typical UVC, which has been used to
kill microorganisms for decades but is carcinogenic and cataractogenic, recent evidence has shown that
far-UVC is safe to use around humans. A high-fidelity, fully-coupled radiation transport and fluid dynamics
model has been developed to quantify disinfection rates within a typical ventilated room. The model
shows that disinfection rates are increased by a further 50-85% when using far-UVC within currently
recommended exposure levels compared to the rooms’ ventilation alone. With these magnitudes of
reduction, far-UVC lighting could be employed to mitigate SARS-CoV-2 transmission before the onset of
future waves, or the start of winter when risks of infection are higher. This is particularly significant in
poorly-ventilated spaces where other means of reduction are not practical, in addition social distancing
can be decreased without increasing the risk.
12
Introduction13
The coronavirus pandemic has put hospitals and long term care facilities under considerable stretch.14
Aerosolised coronavirus released through breathing was probably a significant cause of this1, 2. In these15
environments, and some other populated spaces, social distancing may be impractical and hence the16
infection controls must focus on a combination of personal hygiene and correct use of personal protective17
equipment (PPE). With major shortages seen in many countries, most visibly the supply of N95 face18
masks3, availability of adequate PPE has remained a major concern throughout the crisis. As many19
countries exit their lockdowns, fatigue and habituation within the population may lead to increased20
complacency in hygiene measures, and hence, along with reducing the burden on PPE, controls like21
ultraviolet germicidal irradiation4 (UVGI) have been considered. UVGI has previously been considered22
as a way of controlling airborne viruses during a pandemic if effective vaccines or antiviral drugs are23
not available5. Used for over a hundred years, UVGI-based disinfection traditionally relies on cancer-24
causing 254 nm UVC light thereby rendering it incompatible for use around people. Fortuitously, recent25
advances in UV lamp technology, in particular excimer lamps6–8 and light-emitting diodes9–11, now permit26
narrow bandwidth, short wavelength UVC (207-222 nm) to be generated. As these far-UVC wavelengths27
cannot penetrate either the human stratum corneum or ocular tear layer12, they are not carcinogenic or28
cataractogenic13–17 and can therefore be safely used in people-facing applications18.29
Quantifying the rate of far-UVC viral inactivation within a general room is complex and multiphysics30
in nature. It requires both radiation and atmospheric flow calculations where objects within rooms add31
complication as they obstruct both the light propagation and air flows, thus casting shadows and inducing32
eddies and turbulent structures. High fidelity modelling is therefore essential, and here we present the33
first coupled radiation transport and fluid dynamics simulator, based on the Boltzmann Transport and34
Navier-Stokes equations with integrated Large Eddy Simulation (LES) turbulence models, for viral35
inactivation within atmospheres. Fully resolved spatially distributed far-UVC intensities enable more36
accurate predictions of virus removal over simplified 1/r2 strategies19, diffusion radiation models20, and,37
potentially, empirical data taken from physical measurements21–23. The use of LES models24 provide38
more detailed descriptions of viral transport over other modelling methods, such as Reynolds Averaged39
Navier-Stokes21, 23 or analytical zone-mixing methods23, 25, and despite their increased computational40
requirement, and hence limited use, their importance is now being recognised in the field of atmospheric41
viral transport predictions24.42
This model was used to study the far-UVC inactivation of aerosolised human coronavirus in a single43
occupancy private room, a representative environment found in hospitals and long-term care facilities.44
Conducted in the two-dimensional domain shown in figure 1, the room was of 3 m by 3 m cross-section45
and occupied by a patient laying in a bed. The room was air conditioned with inlet and outlet vents located46
in the top left and top right regions of the ceiling, respectively. Two inlet air velocities, 0.1 ms−1 and47
0.01 ms−1 were analysed. The resulting air changes per hour (ACH) were 8.0 and 0.8, respectively. A48
0.1 m by 0.1 m region above the patient serves as the source zone for virus exhaled by the patient. The49
viral load expelled into the room was modelled in two forms. First was a single 2 second pulse with50
normalised density of 1 pfu.s−1 representing a single unobstructed breath. The second was a series of 251
second pulses with normalised density of 1 pfu.s−1, separated by 2 second pauses, representing continuous52
unobstructed breathing. In all calculations, flow fields were allowed to develop by simulating the air53
conditioning system for 100 seconds before viral release was activated in the source zone. Transport and54
concentration of coronavirus was simulated for a further 2400 seconds, taking into consideration evolving55
flow fields, removal from the outlet vent, inactivation due to far-UVC exposure, and natural losses due to56
the biological half life of approximately 1.2 hours in aerosols26. The source of far-UVC originated from a57
lamp positioned in the top right corner of the room. The power investigated yielded far-UVC intensities of58
approximately 0.0009 mJ.cm−2. s−1 over the region occupied by the patient, and 0.0007-0.0014 mJ.cm−2.59
s−1 at head-height (standing) regions depending on the proximity to the far-UVC lamp. These are close60
to the currently recommended exposure limit12, 27. A far-UVC inactivation value of Z = 4.1 cm2.mJ−161
for human coronavirus was used, based on the most recent estimates and is considered representative of62
SARS-CoV-212.63
Results64
The spatially varying intensity of the far-UVC field produced by the lamp is presented in figure 1. The65
employment of a full Boltzmann solver to resolve the radiation intensity provides an accurate description66
across all space. Here the solution exhibits the typical drop off of intensity away from the lamp, and67
accounts for removal due to interactions with air and the shadows formed from the presence of solid68
objects.69
This radiation field is considered constant in time and is used in all subsequent analysis. Figure 1 also70
presents the flow velocities at 3 time instances of 10, 50 and 100 seconds following the viral release. The71
flow fields have evolved into a quasi-steady state, rotating anti-clockwise, with eddies forming due to the72
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presence of the patient and the bed.73
Figure 1. left to right: Two-dimensional hospital or care home room with bed and patient regions with
superimposed far-UVC intensity field (units mJ.cm−2. s−1): Flow velocity profiles at 10, 50 and 100
seconds following viral release.
Figure 2 shows the viral distributions resulting from the single pulse of SARS-CoV-2 at 10, 50 and 10074
seconds (from viral release) with and without far-UVC light. Apart from reducing peak concentrations,75
a notable feature is the sharp viral reduction in the vicinity of the lamp which, under this setup, has76
prevented some of its re-circulation. This is highlighted by the removal rates presented in the figure; large77
reductions being seen in the upper regions of the room, whilst small reductions are found where far-UVC78
shading is present. The graphs presented in figure 3a compare the room’s total viral concentration over79
time. Without the lamp, 0.8 ACH ventilation results in very slow reductions, but when increased to 8.080
ACH, viral removal through ventilation begins 45 seconds after release and concentrations are reduced by81
90% and 99% in approximately 12 and 24 minutes, respectively. By coincidence, near identical reduction82
times were observed when using far-UVC in combination with 0.8 ACH ventilation, here again taking 1283
and 24 minutes, respectively. The combination of far-UVC and high ventilation reduces the viral count84
most effectively, times to achieve 90% and 99% reductions being approximately 6 and 11.5 minutes,85
respectively, more than halving the times when using 8.0 ACH ventilation alone. Figures 3 b-c present the86
viral concentrations in the 4 regions outlined in figure 1. The highest viral concentrations occur across87
the regions closest to the bed soon after release where the concentrations spike due to their downwind88
positions from the source. Secondary spikes are also observed as the viral plume, which has yet to fully89
dissipate, circulates the room and re-enters the monitored regions. However viral levels over all regions90
converge to similar quantities after about 5 and 12 minutes with 8.0 and 0.8 ACH ventilation, respectively,91
indicating the time taken for the localised viral release to mix homogeneously throughout the room. The92
use of far-UVC results in faster removal of virus at all distances. As before, with 8.0 ACH, the lamp93
reduces the time for similar reductions by more than half. For 0.8 ACH ventilation, given that the viral94
concentration plateaus without the lamp, reduction times are significantly greater.95
The graphs presented in figure 4 show viral concentrations resulting from the source from a repeated96
series of 2 second exhalations. Figure 4a presents the total viral concentration within the room over97
time. With 0.8 ACH ventilation and no far-UVC sterilization, the viral concentration rises steadily for the98
duration of the simulation. When increasing the ventilation to 8.0 ACH, the viral concentration stabilises99
within 18 minutes without far-UVC. By comparison, with 8.0 ACH ventilation, the viral concentration100
with far-UVC also stabilises, but their numbers are reduced by a further 57%. Furthermore, when used in101
combination with 0.8 ACH ventilation, the far-UVC is still more effective that 8.0 ACH ventilation alone,102
where the additional reduction in viral concentration is approximately 20%. Importantly, comparing the103
use of far-UVC with low 0.8 ACH ventilation shows the reduction in viral concentration is approaching an104
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Figure 2. Left to right: Solution profiles at 10, 50 and 100 seconds after release, with 8.0 ACH
ventilation. Top row: Viral distribution without far-UVC. Middle row: Viral distribution with far-UVC,
Bottom row: rate of viral inactivation.
order of magnitude, i.e. a 90% level. At the end of the simulation the reduction was of the order of 85%,105
however the viral concentration was continuing to rise without the far-UVC, thus the indication is that106
reductions will continue to grow over longer timescales.107
Figures 4b-c present the viral concentrations in regions 2 and 4. The SARS-CoV-2 levels are highest108
closer to the viral source, but reductions are observed using far-UVC. With 8 ACH ventilation the far-UVC109
reduces the concentrations in regions 2 and 4 by a further 40% and 52%, respectively. For the lower110
0.8 ACH ventilation, the additional reductions over ventilation increase to 58% and 85%, respectively.111
Interestingly, with 8 ACH ventilation, the average SARS-CoV-2 concentration in region 2 with far-UVC is112
around 24% lower than in region 4 without far-UVC. With 0.8 ACH this increases to 42%. This is despite113
the distance to the source being reduced from 1.25 m to 0.5 m.114
Discussion115
A plethora of approaches are being used to mitigate transmission of aerosolised SARS-CoV-2 coronavirus.116
Others are proposed. Most of these follow one or more of three key principles: minimise time exposed117
to the virus (limit interactions), maximise distance from sources of virus (social distancing), or shield118
yourself from the virus (wear PPE). Whilst these are all effective measures, their success is tied to human119
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(a) (b) (c)
Figure 3. Virus concentration in (a) whole room; (b) regions with 8 ACH; (c) regions with 0.8 ACH.
(a) (b) (c)
Figure 4. Virus concentration in (a) whole room; (b) region 2; (c) region 4.
behaviour and hence at risk from complacency. Unlike these active measures, passive use of in-room120
far-UVC provides an invisible barrier. Whilst the viability of human coronaviruses can be successfully121
reduced by far-UVC12, we have shown that the contention that it can be reduced by 99.9% in public spaces122
within 25 minutes12 is situation dependent. In a representative environment in a hospital or a long-term123
care facility, the nature of the viral source and the interaction of ventilation with far-UVC illumination all124
strongly influence the efficacy of far-UVC germicidal irradiation.125
For poor ventilation and far-UVC human exposures at the currently recommended level, total viable126
viral concentration is reduced exponentially in comparable times to those previously stated12. However, it127
has been shown that this is only the case for a single seeding of virus particles such as those which occur128
from a single unobstructed breath. Such rapid reductions could therefore be achieved in situations where129
face masks or breathing apparatus are removed for a short period of time. Given the normal pattern of130
unobstructed human breathing constantly seeds a poorly-ventilated room with new virus, concentrations131
ultimately reach an equilibrium. With far-UVC illumination at currently recommended exposure levels,132
not only is this equilibrium reached more quickly, but the viral concentration is approximately one order133
of magnitude lower than it would be without. In highly-ventilated rooms, reductions in in-room viral con-134
centration for both breathing scenarios are comparable to those from far-UVC at currently recommended135
exposure levels in poorly-ventilated rooms. Even in highly-ventilated rooms where satisfactory levels of136
removal may already exist, far-UVC illumination will further reduce viral concentrations by around 57%.137
Several practical implications of far-UVC illumination in reducing in-room transmission of SARS-138
CoV-2 are clear. Firstly, with both high and low ventilation, far-UVC will reduce aerosolised SARS-CoV-2139
concentrations within a metre of the patient to levels below that in regions beyond a metre without far-UVC.140
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Employment of far-UVC could therefore have a bearing on the social distancing limits currently used141
in many countries, or at least further reduce risks of transmission at these distances. Secondly, in all142
scenarios described, far-UVC will reduce in-room SARS-CoV-2 concentrations to levels comparable to143
that provided practically by breathing through an N95 mask28, 29. Finally, unlike face masks, far-UVC is144
a passive control from the perspective of the individual. Due to it having a similar efficiency to an N95145
mask, it could replace them in some situations, reducing the demand for PPE supplies, and lessening the146
damage that PPE disposal is causing to the environment30.147
Methods148
The survival rate S of a viral population subjected to some UVC radiation intensity over a time period of t
seconds is governed by the equation,
S = e−Zd = e−ZEpt , (1)
as described in4. The UVC intensity with dimension mJ.cm−2. s−1 is denoted by Ep, and the dose received149
(with units mJ.cm−2) is denoted by d = Ept. The key parameter governing the rate of viral inactivation is150
the susceptibility value Z, with units cm2.mJ−1. This susceptibility value is dependent on both the virus151
type and its hosting media. Relating to SARS-CoV-2 estimates of Z have been provided in12 which states152
a value 4.1cm2.mJ−1 for moist air conditions.153
Far-UVC Radiation Transport Model154






Σs(r,Ω′→Ω)E(r,Ω′)dΩ′ = S(r,Ω). (2)
The radiation intensity distribution E(r,Ω) exists within a 5 dimensional phase-space consisting of 3155
space dimensions, r, and 2 in angle Ω, with units mJ.cm−2. s−1. The equation describes the transport156
of far-UVC photon energy and includes the photon interaction with their surrounding media through157
absorption and scattering which are characterised by the cross-sections Σt(r) and Σs(r), respectively. The158
source of far-UVC emanating from a lamp is described through the term S(r,Ω).159
The solution to equation 2 was obtained via a model using discontinuous finite elements and discrete160
ordinates for resolving the spatial and angular dimensions respectively. The solutions presented here used161
a uniform mesh of 150×150 quadrilateral elements with linear basis functions. A high order S80 angular162
discretisation was employed to resolve the direction of photon travel. In 2D this used 3280 directions163
which provided sufficient resolution to cover the whole room with far-UVC with reduced oscillations from164
ray-effects. This space-angle discretisation resulted in a total of around 295 million degrees of freedom165
for the whole radiation solution.166
The scalar quantity of the spatially dependent far-UVC intensity, Ep(r), that irradiates airborne virus





The material cross-sections were derived from a number of sources and was based on dry air, these are167
summarised in table 1.168
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Fluid Flow Model for Room Ventilation169
Computational fluid dynamics is a numerical approach for simulating the movement of air based on the
conservation laws of mass, momentum, and energy. Ignoring the temperature influences, the airflow
motion is governed by the following form of the unsteady, incompressible Navier-Stokes equations:
∇ ·u = 0,
ut +u ·∇u+∇p−ν∇2u = 0.
(4)
The velocity of air is denoted by the 3 component vector u = (u,v,w) which holds the respective air170
velocities in the x, y and z dimensions, and p denotes the pressure. The kinematic viscosity of air is171
denoted by ν and has the value 1.5×10−5 m2.s. With room side lengths of 3m and with inlet velocity172
0.1 ms−1, for 8 ACH ventilation, the Reynolds number (Re = UL
ν
) for this problem was approximately173
30,000.174
In the simulations presented a finite element discretisation of the governing equations 4 was used31.175
A regular mesh of 300×300 quadrilateral elements was employed upon which both the velocities and176
pressures were resolved using continuous linear basis functions. The transient process was resolved using177
the explicit Adams–Bashforth stepping scheme. A Large Eddy Simulation was embedded in the fluid178
solver for resolving the the flows’ turbulent features. The full details of the finite element discretisation of179
the equations (4-5) and the LES model are discussed in31.180
UVC inactivation model181
The distribution and transportation of the airborne virus was included in the room ventilation model. The
spatially dependent scalar concentration of the virus was described through the equation,
(φt +u ·∇φ) = ∇2Dφ +Sφ −ZEpφ −αφ . (5)
The variable φ denotes the concentration of virus per unit volume (pfu.cm−3) which is transported through182
convection with the air flow u and via diffusion with coefficient D. The SARS-CoV-2 source is defined183
by Sφ , and its removal is defined through the last term of equation 5. This removal accounts for the184
inactivation due to the far-UVC intensity field Ep, with Z being the far-UVC susceptibility constant. The185
natural death rate, or half life of SARS-CoV-2 has been considered in the model. The decay rate α is186
estimated by the reported virus half life of approximately 1.2 hours in aerosols26.187
In the results presented the same spatial and temporal discretisation as the fluid model were used. The188
far-UVC intensity field in equation 3, which was resolved on a different mesh, was conservatively mapped189
onto the fluids mesh to enable the calculation of viral removal.190
The use of equation 5 implies the model is concerned with the virus contained within those droplets191
sufficiently small to remain airborne for periods lasting 10’s of minutes. Thus the larger droplets heavily192
influenced by gravity and which fall to ground are not considered here. Settling velocities, with typical193
values of 0.06-0.35 cm. s−132, and evaporation of droplets have also been omitted from consideration.194
The droplet’s convection with the air flow is the dominant transport process, and so gravitational effects195
are small, and any size reduction due to evaporation increases this effect. The resting of droplets on196
surfaces are currently not included in this model as the analysis centres on the droplets that remain airborne.197
However, the percentage of those droplets that do come to rest will still be subjected to far-UVC irradiation,198
but will not be removed through ventilation. Therefore the estimates of removal via the far-UVC are199
conservative, and the true removal rates are potentially greater.200
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Physical Properties and Model Parameters201
Table 1 listed all the physical properties and parameters used in the numerical models. The two corners for202
the bed, head and far-UVC source are located at (1.0, 0.4) and (2.0, 0.7), (1.4,0.6) and (1.6, 0.9), (2.8, 2.8)203
and (3.0, 3.0), respectively.
Table 1. Physical properties and parameters in the numerical experiments
Symbol Description Units Example case
λ far-UVC wavelength nm 222
S far-UVC source mJ.cm−2. s−1 0.0022
Σt absorption cross section of air cm−1 2.83×10−5
Σs scattering cross section of air cm−1 4.6×10−6
ν air kinematic viscosity m2 s−1 1.5×10−5
D diffusion coefficient m2 s−1 1.0×10−3
v ventilation inlet flow velocity m s−1 0.01−0.1
ACH air change per hour None 0.8−8.0
Z virus UVC susceptibility constant cm2 mJ−1 4.1
α SARS-CoV-2 decay rate in aerosols None 1.6×10−4
L room width and height m 3.0
204
Data availability205
Source data files are provided with this paper for Fig. 1 - Fig. 4. at: https://github.com/agbuchan/UVCdata.206
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